Prosight Management, LP Ultragenyx Pharmaceutical Inc. Transaction History

Prosight Management, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 14, 2018	SELL	$44.33 - $58.52 $1.98 Million - $2.61 Million	-44,600 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$43.54 - $57.32 $1.94 Million - $2.56 Million	44,600	44,600 $2.07 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.15B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.